Detalhe da pesquisa
1.
Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest.
Mol Cell
; 83(22): 4047-4061.e6, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977117
2.
Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.
Oncologist
; 26(11): e1962-e1970, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34390291
3.
Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.
Clin Adv Hematol Oncol
; 19(3): 155-161, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739964
4.
Circulating Tumor DNA: Measurement and Clinical Utility.
Annu Rev Med
; 69: 223-234, 2018 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28846488
5.
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors.
Breast Cancer Res Treat
; 181(2): 297-307, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277377
6.
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties.
Breast Cancer Res Treat
; 179(3): 631-642, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823098
7.
Undetectable Tumor Cell-Free DNA in a Patient With Metastatic Breast Cancer With Complete Response and Long-Term Remission.
J Natl Compr Canc Netw
; 18(4): 375-379, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259780
8.
BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells.
Breast Cancer Res
; 21(1): 51, 2019 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995943
9.
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies.
Breast Cancer Res Treat
; 174(2): 401-412, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30560461
10.
NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.
Mol Cell
; 44(4): 609-20, 2011 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22099308
11.
A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencing.
Breast Cancer Res Treat
; 170(2): 425-430, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29541976
12.
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Breast Cancer Res Treat
; 168(3): 695-702, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29297111
13.
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability.
Proc Natl Acad Sci U S A
; 112(37): 11583-8, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26324937
14.
HER2 missense mutations have distinct effects on oncogenic signaling and migration.
Proc Natl Acad Sci U S A
; 112(45): E6205-14, 2015 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508629
15.
Call for action: expanding global access to hereditary cancer genetic testing.
Lancet Oncol
; 23(9): 1124-1126, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055301
16.
Use of cell free DNA in breast oncology.
Biochim Biophys Acta
; 1865(2): 266-74, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27012505
17.
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.
Breast Cancer Res
; 19(1): 60, 2017 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28535794
18.
PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity.
Breast Cancer Res Treat
; 162(3): 451-464, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28190247
19.
Single-Nucleotide Polymorphism Leading to False Allelic Fraction by Droplet Digital PCR.
Clin Chem
; 63(8): 1370-1376, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28615231
20.
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.
Mol Cell Proteomics
; 14(7): 1959-76, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953087